Schroeder Thilo's Form 4 filing
PMV Pharmaceuticals, Inc. (PMVP) · filed Sep 13, 2021
- Accession no.
- 0001209191-21-055782
- Filed
- Sep 13, 2021
- Trade date
- Sep 9-13, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $2.15M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2021 | Common Stock | SSaleDisposed | −14,329 | $30.31 | −$434,311.99 | 1,181,473 | Indirect | |
| Sep 10, 2021 | Common Stock | SSaleDisposed | −38,056 | $30.44 | −$1,158,424.64 | 1,143,417 | Indirect | |
| Sep 10, 2021 | Common Stock | SSaleDisposed | −5,171 | $31.03 | −$160,456.13 | 1,138,246 | Indirect | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −13,272 | $30.20 | −$400,814.4 | 1,124,974 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.